论文部分内容阅读
肺癌是全世界最常见恶性肿瘤之一,大多数患者确诊时已失去手术治疗机会。随着介入治疗领域的不断发展,探讨肺癌供血对介入治疗方法和疗效的影响、对支气管动脉作为肺癌的主要供血来源、支气管动脉灌注化疗药物(BAI)的选择及方法、支气管动脉栓塞(BAE)治疗的栓塞剂选择和支气管动脉灌注治疗并发症的预防以及支气管动脉灌注治疗在非小细胞肺癌综合治疗中的作用等已普遍受到关注。本文就肺癌的供血、支气管动脉插管化疗、栓塞及栓塞并发症的预防等的支气管动脉灌注治疗现状进行综述。
Lung cancer is one of the most common malignancies in the world and most patients have lost the chance of surgery when diagnosed. With the development of interventional therapy, the influence of lung cancer blood supply on the interventional therapy and curative effect is discussed. The bronchial artery is the main source of lung cancer, the choice and method of bronchial arterial infusion chemotherapy (BAI), bronchial artery embolization (BAE) The choice of embolic agent for treatment and the prevention of complications in the treatment of bronchial arterial infusion and the role of bronchial arterial infusion in the comprehensive treatment of non-small cell lung cancer have received widespread attention. This review summarizes the current status of bronchial arterial perfusion for the supply of lung cancer, bronchial arterial cannulation and chemotherapy, and the prevention of embolization and embolization complications.